101 related articles for article (PubMed ID: 30116813)
21. Design of a small molecule against an oncogenic noncoding RNA.
Velagapudi SP; Cameron MD; Haga CL; Rosenberg LH; Lafitte M; Duckett DR; Phinney DG; Disney MD
Proc Natl Acad Sci U S A; 2016 May; 113(21):5898-903. PubMed ID: 27170187
[TBL] [Abstract][Full Text] [Related]
22. Epigenetically silenced microRNAs in gastric cancer: Functional analysis and identification of their target genes.
Bae JH; Kang MJ; Yang KM; Kim TO; Yi JM
Oncol Rep; 2015 Aug; 34(2):1017-26. PubMed ID: 26043902
[TBL] [Abstract][Full Text] [Related]
23. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.
Wang Z; Ma X; Cai Q; Wang X; Yu B; Cai Q; liu B; Zhu Z; Li C
FEBS Lett; 2014 Nov; 588(23):4504-12. PubMed ID: 25448600
[TBL] [Abstract][Full Text] [Related]
24. miR-375 inhibits Helicobacter pylori-induced gastric carcinogenesis by blocking JAK2-STAT3 signaling.
Miao L; Liu K; Xie M; Xing Y; Xi T
Cancer Immunol Immunother; 2014 Jul; 63(7):699-711. PubMed ID: 24718681
[TBL] [Abstract][Full Text] [Related]
25. Design, Synthesis, and Evaluation of Neomycin-Imidazole Conjugates for RNA Cleavage.
Martin C; Bonnet M; Patino N; Azoulay S; Di Giorgio A; Duca M
Chempluschem; 2022 Nov; 87(11):e202200250. PubMed ID: 36148854
[TBL] [Abstract][Full Text] [Related]
26. Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction.
Chen J; Sun D; Chu H; Gong Z; Zhang C; Gong B; Li Y; Li N; Jiang L
Oncol Rep; 2015 Jun; 33(6):2963-71. PubMed ID: 25964059
[TBL] [Abstract][Full Text] [Related]
27. Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer.
Pavithra D; Sabitha K; Rajkumar T
Comput Biol Chem; 2018 Dec; 77():442-454. PubMed ID: 30100328
[TBL] [Abstract][Full Text] [Related]
28. Abberent expression of oncogenic and tumor-suppressive microRNAs and their target genes in human adenocarcinoma alveolar basal epithelial cells.
Tafsiri E; Darbouy M; Shadmehr MB; Cho WC; Karimipoor M
J Cancer Res Ther; 2016; 12(1):395-400. PubMed ID: 27072269
[TBL] [Abstract][Full Text] [Related]
29. Fluorescent HIV-1 Dimerization Initiation Site: design, properties, and use for ligand discovery.
Tam VK; Kwong D; Tor Y
J Am Chem Soc; 2007 Mar; 129(11):3257-66. PubMed ID: 17319662
[TBL] [Abstract][Full Text] [Related]
30. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
[TBL] [Abstract][Full Text] [Related]
31. Design of Multimodal Small Molecules Targeting miRNAs Biogenesis: Synthesis and In Vitro Evaluation.
Vo DD; Duca M
Methods Mol Biol; 2017; 1517():137-154. PubMed ID: 27924480
[TBL] [Abstract][Full Text] [Related]
32. A comprehensive search for microRNAs with expression profiles modulated by oncogenic KRAS: potential involvement of miR-31 in lung carcinogenesis.
Okudela K; Suzuki T; Umeda S; Tateishi Y; Mitsui H; Miyagi Y; Ohashi K
Oncol Rep; 2014 Oct; 32(4):1374-84. PubMed ID: 25050641
[TBL] [Abstract][Full Text] [Related]
33. Involvement of aberrant miR-139/Jun feedback loop in human gastric cancer.
Zhang Y; Shen WL; Shi ML; Zhang LZ; Zhang Z; Li P; Xing LY; Luo FY; Sun Q; Zheng XF; Yang X; Zhao ZH
Biochim Biophys Acta; 2015 Feb; 1853(2):481-8. PubMed ID: 25499265
[TBL] [Abstract][Full Text] [Related]
34. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
[TBL] [Abstract][Full Text] [Related]
35. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2.
Ding L; Xu Y; Zhang W; Deng Y; Si M; Du Y; Yao H; Liu X; Ke Y; Si J; Zhou T
Cell Res; 2010 Jul; 20(7):784-93. PubMed ID: 20548334
[TBL] [Abstract][Full Text] [Related]
36. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
[TBL] [Abstract][Full Text] [Related]
37. Splicing-dependent expression of microRNAs of mirtron origin in human digestive and excretory system cancer cells.
Butkytė S; Čiupas L; Jakubauskienė E; Vilys L; Mocevicius P; Kanopka A; Vilkaitis G
Clin Epigenetics; 2016; 8():33. PubMed ID: 27019673
[TBL] [Abstract][Full Text] [Related]
38. Design and Implementation of Synthetic RNA Binders for the Inhibition of miR-21 Biogenesis.
Maucort C; Vo DD; Aouad S; Charrat C; Azoulay S; Di Giorgio A; Duca M
ACS Med Chem Lett; 2021 Jun; 12(6):899-906. PubMed ID: 34141067
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma.
Kong WQ; Bai R; Liu T; Cai CL; Liu M; Li X; Tang H
FEBS J; 2012 Apr; 279(7):1252-60. PubMed ID: 22325466
[TBL] [Abstract][Full Text] [Related]
40. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.
Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF
Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
